SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Penn I. Malignancies associated with transplantation. Urology 1977; 10 (Suppl): 5763.
  • 2
    Paul P, Adrian Cabestre F, Le Gal FA, Khalil Daher I, Ledanff C, Schmid M, Mercier S, Avril MF, Dausset J, Guillet JG, Carosella ED. heterogeneity of HLA G transcription and protein expression in melanoma biopsies Cancer Res 1999; 59: 195460.
  • 3
    Wagner SN, Rebmann V, Willers CP, Grosse-Wilde H, Goos M. Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanoma. Lancet 2000; 356: 2201.
  • 4
    Fukushima Y, Oshika Y, Nakamura M, Tokunaga T, Hatanaka H, Abe Y, Yamazaki H, Kijima H, Ueyama Y, Tamaoki N. Increased expression of HLA G in colorectal cancers. Int J Mol Med 1998; 2: 34951.
  • 5
    Pangault C, Le Friec G, Caulet-Maugendre S, Lena H, Amiot L, Guilloux V, Onno M, Fauchet R. Lung macrophages and dendritic cells express HLA-G molecules in pulmonary diseases. Immunology 2002; 63: 8390.
  • 6
    El Cherif I, Guerra N, Terrier Lacombe MJ, Angevin E, Chouaib S, Carosella ED, Caignard A, Paul P. Tumor specific up regulation of the non classical class I HLA G antigen expression in renal carcinoma. Cancer Res 2001; 15: 683845.
  • 7
    Lefebvre S, Antoine M, Uzan S, McMaster M, Dausset J, Carosella ED, Paul P. Specific activation of the nonclassical HLA G antigen and expression of the ILT2 inhibitory receptor in breast carcinomas. J Pathol 2002; 196: 26674.
  • 8
    Urosevic M, Kurrer MO, Kamarashev J, Mueller B, Weder W, Burg G, Stahel RA, Dummer R, Trojan A. Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production. Am J Pathol 2001; 159: 81724.
  • 9
    Ugurel S, Rebmann V, Ferrone S, Tilgen W, Grosse-Wilde H, Reinhold U. Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy. 2001; 92: 36976.
  • 10
    Urosevic M, Willers J, Mueller B, Kempf W, Burg G, Dummer R. HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas. Blood 2002; 99: 60917.
  • 11
    Le Gal FA, Riteau B, Sedlik C, Khalil-Daher I, Menier C, Dausset J, Guillet JG, Carosella ED, Rouas-Freiss N. HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunity 1999; 11: 1016.
  • 12
    Rouas-Freiss N, Marchal R, Kieszenbaum M, Dausset J, Carosella ED. The α domain of HLA-G1 ant HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer inhibitory receptors? Proc Natl Acad Sci USA 1997; 94: 524954.
  • 13
    Navarro F, Llano M, Bellon T, Colonna M, Geraghty DE, Lopez-Botet M. The ILT2 (LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur J Immunol 1999; 29: 27783.
  • 14
    Riteau B, Menier C, Khalil-Daher I, Dausset J, Rouas-Freiss N, Carosella ED. HLA-G inhibits the allogeneic proliferative response. J Reprod Immunol 1999; 43: 20311.
  • 15
    Bainbridge DR, Ellis SA, Sargent IL. HLA-G suppresses proliferation of CD4+ T-lymphocytes. J Reprod Immunol 2000; 48: 1726.
  • 16
    Lila N, Carpentier A, Amrein C, Khalil Daher I, Dausset J, Carosella EED. Implication of HLA-G molecule in heart-graft acceptance. Lancet 2000; 355: 2138.
  • 17
    Lila N, Amrein C, Guillemain R, Chevalier P, Latremouille C, Fabiani JN, Dausset J, Carosella ED, Carpentier A. HLA-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 2002; 105: 194954.
  • 18
    Paul P, Rouas-Freiss N, Moreau P, Cabestre FA, Menier C, Khalil-Daher I, Pangault C, Onno M, Fauchet R, Martinez-Laso J, Morales P, Villena AA, et al. HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression. Hum Immunol 2000; 61: 117795.
  • 19
    Carosella ED, Rouas-Freiss N, Paul P, Dausset J. HLA-G: a tolerance molecule from the major histocompatibility complex. Immunol Today 1999; 20: 602.
  • 20
    Colonna M, Navarro F, Bellon T, Llano M, Garcia P, Samaridis J, Angman L, Cella M, Lopez-Botet M. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 1997; 186: 180918.
  • 21
    Ponte M, Cantoni Biassoni R, Radori-Cappai A, Bentivoglio G, Vitale C, Bertone S, Moretta A, Moretta L, Mingari MC. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci USA 1999; 96: 56749.
  • 22
    Riteau B, Rouas-Freiss N, Menier C, Paul P, Dausset J, Carosella ED. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol 2001; 166: 501826.
  • 23
    Aractingi S, Briand N, Le Danff C, Viguier M, Bachelez H, Michel L, Dubertret L, Carosella ED. HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells? Am J Pathol 2001; 159: 717.
  • 24
    Khosrotehrani K, LeDanff C, Dubertret L, Raynaud Mandel B, Carosella ED, Aractingi S. HLA G is expressed in atopic dermatitis. J Invest Dermatol 2001; 117: 7502.
  • 25
    Fournel S, Aguerre-Girr M, Huc X, Lenfant F, Alam A, Toubert A, Bensussan A, Le Bouteiller P. Soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 2000; 164: 61004.
  • 26
    Urosevic M, Trojan A, Dummer R. HLA-G and its KIR ligands in cancer—another enigma yet to be solved? J Pathol 2002; 196: 2523.
  • 27
    Liang S, Baibakov B, Horuzsko A. HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor. Eur J Immunol 2002; 32: 241826.
  • 28
    Yang Y, Chu W, Geraghty DE, Hunt JS. Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-γ. J Immunol 1996; 156: 422431.
  • 29
    Moreau P, Adrian Cabestre F, Menier C, Guiard V, Gourand L, Dausset J, Carosella ED, Paul P. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int Immunol 1999; 11: 80311.
  • 30
    Asderakis A, Sankaran D, Dyer P, Johnson RW, Pravica V, Sinnott PJ, Roberts I, Hutchinson IV. Association of polymorphisms in the human interferon-gamma and interleukin-10 gene with acute and chronic kidney transplant outcome: the cytokine effect on transplantation. Transplantation 2001; 71: 6747.
  • 31
    Onno M, Le Friec G, Pangault C, Amiot L, Guilloux V, Drenou B, Caulet-Maugendre S, Andre P, Fauchet R. Modulation of HLA-G antigens expression in myelomonocytic cells. Hum Immunol 2000; 61: 108694.
  • 32
    Liddington M, Richardson AJ, Higgins RM, Endre ZH, Venning VA, Murie JA, Morris PJ. Skin cancer in renal transplant recipients. Br J Surg 1989; 76: 10025.
  • 33
    Bouwes Bavinck JN, Hardie D, Green A, Cutmore S, MacNaught A, O'Sullivan B, Siskind V, Van Der Woude FJ, Hardie IR. The risk of skin cancer in renal transplant recipients in Queensland, Australia. Transplantation 1996; 61: 71521.
  • 34
    Euvrard S, Kanitakis J, Pouteil-Noble C, Claudy A, Touraine JL. Skin cancers in organ transplant recipients. Ann Transplant 1997; 2: 2832.
  • 35
    Hartevelt MM, Bavinck JN, Kootte AM, Vermeer BJ, Vandenbroucke JP. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990; 49: 5069.
  • 36
    Hardie IR, Strong RW, Hartley LC, Woodruff PW, Clunie GJ. Skin cancer in Caucasian renal allograft recipients living in a subtropical climate. Surgery 1980; 87: 1778.
  • 37
    McGregor JM, Berkhout RJ, Rozycka M, ter Schegget J, Bouwes Bavinck JN, Brooks L, Crook T. p53 mutations implicate sunlight in post-transplant skin cancer irrespective of human papillomavirus status. Oncogene 1997; 15: 173740.
  • 38
    Euvrard S, Chardonnet Y, Pouteil-Noble C, Kanitakis J, Chignol MC, Thivolet J, Touraine JL. Association of skin malignancies with various and multiple carcinogenic and noncarcinogenic human papillomaviruses in renal transplant recipients. Cancer 1993; 72: 2198206.
  • 39
    Arends MJ, Benton EC, McLaren KM, Stark LA, Hunter JA, Bird CC. Renal allograft recipients with high susceptibility to cutaneous malignancy have an increased prevalence of human papillomavirus DNA in skin tumours and a greater risk of anogenital malignancy. Br J Cancer 1997; 75: 7228.
  • 40
    Harwood CA, Surentheran T, McGregor JM, Spink PJ, Leigh IM, Breuer J, Proby CM. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000; 61: 28997.
  • 41
    de Jong-Tieben LM, Berkhout RJ, Smits HL, Bouwes Bavinck JN, Vermeer BJ, van der Woude FJ, ter Schegget J. High frequency of detection of epidermodysplasia verruciformis–associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients. J Invest Dermatol 1995; 105: 36771.
  • 42
    Boxman IL, Berkhout RJ, Mulder LH, Wolkers MC, Bouwes Bavinck JN, Vermeer BJ, ter Schegget J. Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol 1997; 108: 7125.
  • 43
    Viac J, Chardonnet Y, Euvrard S, Chignol MC, Thivolet J. Langerhans cells, inflammation markers and human papillomavirus infections in benign and malignant epithelial tumors from transplant recipients. J Dermatol 1992; 19: 6777.
  • 44
    Galvao MM, Sotto MN, Kihara SM, Rivitti EA, Sabbaga E. Lymphocyte and subsets and Langerhans cells in sun-protected and sun-exposed skin of immunosuppressed renal allograft recipients. J Am Acad Dermatol 1988; 38: 3844.
  • 45
    Marshall SE, Bordea C, Haldar NA, Mullighan CG, Wojnarowska F, Morris PJ, Welsh KI. Glutathione S-transferase polymorphisms and skin cancer after renal transplantation. Kidney Int 2000; 58: 218693.
  • 46
    O Connor DP, Kay EW, Leader M, Murphy GM, Atkins GJ, Mabruk MJ. A high degree of chromosomal instability at 13q14 in cutaneous squamous cell carcinomas: indication for a role of a tumour suppressor gene other than Rb. Mol Pathol 2001; 54: 1659.